Economic Cost and Sustainability of Oral Therapies in Precision Oncology.
Aakash P DesaiCaleb J ScheckelLeah C SoderbergChelsee Jo JensenJacob J OrmeSri H TellaAnuhya KommalapatiJoshua C PritchettNandita KheraAmit MahipalRonald S Gonull nullPublished in: JCO oncology practice (2022)
The median CAGR in costs for modern oral precision-driven cancer therapeutic classes mostly outpaced CPI and the average inflation. Increase in cost within the same class should be weighed against incremental clinical benefit for the patients to ensure that rising costs do not limit access to targeted therapies.